Impact of Incorporated Drugs on the Properties of Hydrophilic Nanofibers

Kocbek Daraei^*
*Correspondence: Kocbek Daraei, Department of Pharmaceutical Technology, University of Zurich, 8006 Zurich, Switzerland, Email:

Keywords

Hydrophilic nanofibers • Drug incorporation • Electrospinning • Fiber morphology • Mechanical strength • Drug release profiles

Introduction

Hydrophilic nanofibers, characterized by their high surface area-tovolume ratio and enhanced porosity, have become increasingly significant in biomedical applications. These nanofibers are particularly valued for their potential in drug delivery systems, wound healing, and tissue engineering. Their effectiveness, however, can be markedly influenced by the incorporation of drugs. This article explores how the inclusion of pharmaceuticals affects the properties of hydrophilic nanofibers, focusing on key aspects such as fiber morphology, mechanical properties, hydrophilicity, and drug release behavior [1].

Several techniques are employed to incorporate drugs into hydrophilic nanofibers. Electrospinning is one of the most common methods, allowing for the creation of nanofibers with a high drug content while maintaining their structural integrity. Another approach is solution blending, where drugs are mixed with polymer solutions before fiber formation. Each method has its implications for the final properties of the nanofibers. The incorporation of drugs into hydrophilic nanofibers can alter their morphology. Drug particles can affect the fiber diameter, surface texture, and overall uniformity. For instance, high drug loads may lead to an increase in fiber diameter or cause irregularities in the fiber surface. These morphological changes can impact the nanofibers' performance in applications such as drug delivery, where surface characteristics play a critical role [2].

Literature Review

The mechanical strength of hydrophilic nanofibers can be influenced by the type and concentration of the incorporated drug. Generally, drug incorporation might result in a reduction of tensile strength and elongation at break, depending on the drug's physical and chemical properties. This is crucial for applications requiring specific mechanical properties, such as scaffolds in tissue engineering. Hydrophilicity is a key property of hydrophilic nanofibers that affects their interaction with biological fluids and tissues. The presence of drugs can alter the hydrophilic nature of the fibers. For instance, hydrophobic drugs can decrease the overall hydrophilicity of the fibers, potentially affecting their wettability and interaction with aqueous environments. Conversely, hydrophilic drugs may enhance the fibers' water affinity. The release kinetics of drugs from hydrophilic nanofibers is a major concern in drug delivery applications. Drug incorporation influences release profiles, including the rate and duration of release. Factors such as drug solubility, fiber composition, and drug-polymer interactions play a role in determining how effectively and steadily drugs are released from the nanofibers. Controlled and sustained release profiles are often desirable in therapeutic applications to ensure prolonged efficacy [3].

The modifications in properties resulting from drug incorporation have direct implications for various biomedical applications. In drug delivery systems, altered fiber morphology and hydrophilicity can affect drug absorption and bioavailability. In wound healing, changes in mechanical strength and hydrophilicity can influence the nanofiber's performance as a wound dressing. Similarly, in tissue engineering, the mechanical and release properties of drug-loaded nanofibers are critical for their effectiveness as scaffolds. Incorporating drugs into hydrophilic nanofibers significantly impacts their properties, including morphology, mechanical strength, hydrophilicity, and drug release profiles. Understanding these effects is essential for optimizing nanofiber-based systems for specific applications in drug delivery and other biomedical fields. Future research should focus on developing strategies to control and predict these impacts to enhance the performance and efficacy of drug-loaded hydrophilic nanofibers [4].

Developing new or refined methods for drug incorporation can improve the uniformity and control over drug release profiles. Techniques such as co-electrospinning, core-shell electrospinning, and dual-spinneret electrospinning offer potential for enhancing drug distribution and release rates. Research should focus on creating nanofibers with tailored release profiles to meet specific therapeutic needs. This involves engineering the nanofiber matrix to control drug diffusion, degradation rates, and interaction with the drug, potentially incorporating stimuli-responsive materials to trigger drug release. Evaluating the biocompatibility and potential toxicity of drugloaded nanofibers is crucial. Detailed in vivo studies are needed to assess the safety and effectiveness of these materials in clinical settings, including their long-term effects on human tissues and organs [5].

Discussion

Functionalizing nanofibers with targeting moieties or bioactive molecules can enhance their specificity and efficacy in drug delivery applications. Surface modifications might improve cell adhesion in tissue engineering or increase the therapeutic efficacy in targeted drug delivery. Combining multiple functionalities in a single nanofiber system could offer new possibilities. For instance, incorporating imaging agents, therapeutic drugs, and diagnostic tools into nanofibers can create multifunctional platforms for simultaneous diagnosis and therapy. Developing scalable and cost-effective manufacturing processes is essential for translating laboratory research into clinical and commercial applications. Innovations in production techniques and material sourcing can enhance the feasibility of large-scale production of drug-loaded nanofibers. Addressing regulatory requirements and standardizing fabrication processes will be critical for the successful commercialization of drug-loaded nanofibers. Establishing clear guidelines for quality control and testing can facilitate the approval and adoption of these materials in clinical practice [6].

Conclusion

The incorporation of drugs into hydrophilic nanofibers significantly impacts their properties, such as morphology, mechanical strength, hydrophilicity, and drug release behavior. Understanding these impacts is crucial for optimizing nanofiber-based drug delivery systems and other biomedical applications. Continued research and innovation are needed to address current challenges, enhance performance, and ensure the safe and effective use of drug-loaded nanofibers in clinical settings. The field of nanofiber technology holds great promise for advancing drug delivery and other biomedical applications. By focusing on the areas outlined above, researchers can develop more effective, targeted, and safe nanofiber-based systems to meet a wide range of medical needs.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Dong, Xiangyu, Qian Sun, Jiwen Geng and Xiaojing Liu, et al. "Fiber flexibility reconciles matrix recruitment and the fiber modulus to promote cell mechanosensing."Nano Lett 24 (2024): 4029-4037.

   Google Scholar, Crossref, Indexed at

2. Dragar, Črt, Nives Ileršič, Tanja Potrč and Sebastjan Nemec, et al. "Electrospinning as a method for preparation of redispersible dry product with high content of magnetic nanoparticles."Int J Pharm 629 (2022): 122389.

   Google Scholar, Crossref, Indexed at

3. Zupančič, Špela, Luca Casula, Tomaž Rijavec and Aleš Lapanje, et al. "Sustained release of antimicrobials from double-layer nanofiber mats for local treatment of periodontal disease, evaluated using a new micro flow-through apparatus."J Control Release 316 (2019): 223-235.

   Google Scholar, Crossref, Indexed at

4. Sharma, Rahul, Tarun Garg, Amit K. Goyal and Goutam Rath. "Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis."Artif cells Nanomed Biotechnol 44 (2016): 524-531.

   Google Scholar, Crossref, Indexed at

5. Fu, Ruoqiu, Chenwen Li, Caiping Yu and Hong Xie, et al. "A novel electrospun membrane based on moxifloxacin hydrochloride/poly (vinyl alcohol)/sodium alginate for antibacterial wound dressings in practical application."Drug Deliv 23 (2016): 818-829.

   Google Scholar, Crossref, Indexed at

6. Hilal Algan, Aslihan, Nursel Pekel-Bayramgil, Fatih Turhan and Nurten Altanlar. "Ofloxacin loaded electrospun fibers for ocular drug delivery: Effect of formulation variables on fiber morphology and drug release."Curr Drug Deliv 13 (2016): 433-443.

   Google Scholar, Crossref, Indexed at